CrossrefInfokarte
Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series
Transplantation Proceedings · 2026-10 · 58 (8) · 1527-1531
DOI: 10.1016/j.transproceed.2026.07.030 ↗Abstract
Kein Abstract verfügbar.
EUVIMED